Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease

Trial Profile

Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Dec 2014

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol succinate
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms ENCOMPASS
  • Most Recent Events

    • 21 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 04 Mar 2014 According to ClinicalTrials.gov record planned end date changed from 1 Dec 2013 to 1 Dec 2015.
    • 09 May 2013 Planned end date changed from 1 Nov 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top